MEVIC
Molecular engineering of virus-like carriers
| Coordinatore |
Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie. |
| Nazionalità Coordinatore | Non specificata |
| Totale costo | 1˙643˙736 € |
| EC contributo | 16 € |
| Programma | FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
| Anno di inizio | 2011 |
| Periodo (anno-mese-giorno) | 2011-10-01 - 2016-09-30 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
THE UNIVERSITY OF SHEFFIELD
Organization address
address: FIRTH COURT WESTERN BANK contact info |
UK (SHEFFIELD) | beneficiary | 436˙830.70 |
| 2 |
UNIVERSITY COLLEGE LONDON
Organization address
address: GOWER STREET contact info |
UK (LONDON) | hostInstitution | 1˙206˙905.40 |
| 3 |
UNIVERSITY COLLEGE LONDON
Organization address
address: GOWER STREET contact info |
UK (LONDON) | hostInstitution | 1˙206˙905.40 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'In the last 5 years I have been working on the study of nanoscopic vesicles formed by the assembly in water of amphiphilic block copolymers. These polymer vesicles also known as polymersomes can be designed with size, topology and morphology similar to natural viruses. The synthetic nature of copolymers allows the design of interfaces with various classes of biochemically-active functional groups. This, in combination with precise control over the molecular architecture, determines the degree of order in self-organizing polymeric materials. Such bio-inspired ‘bottom-up’ supramolecular design principles can offer outstanding advantages in engineering structures at a molecular level, using the same long–studied principles of biological molecules. It is self-evident that the highly biocompatible nature of these new amphiphilic copolymer assemblies augurs well for biomedical applications. Indeed, related polymeric micelles and vesicles have already been reported and studied as delivery systems for drugs, gene, and image contrast agents. Herein I propose to engineer new generations of polymersomes whose size, topology, surface chemistry is exquisitely controlled by supramolecular interactions with the aim to control their bioactivity and explore new ways to target specific biological sites via multi-fictionalisation and steric controlled binding. This will be achieved by a balanced combination of novel physico-chemical techniques with tailor-made biological evaluation based on state-of-the-art cell culture methods as well as in vitro and in vivo high content screening. My long-term aim is to set-up new design principles for nanoparticles for biomedical applications together with a thorough biomedical fast screening that will enable safe and fast translation into the clinic as well as benchmarking nanotoxicological methodologies.'